ClavystBio
ClavystBio and A*STAR partner to grow MedTech ventures in Singapore
ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector research and development (R&D) agency, have signed a memorandum of understanding (MoU) to create and grow MedTech ventures in Singapore.
June 11, 2025
VinFast remains in the red in Q2 despite higher revenue
September 5, 2025
Ant International’s Antom debuts agentic payment solution
September 5, 2025
VinFast remains in the red in Q2 despite higher revenue
September 5, 2025
Ant International’s Antom debuts agentic payment solution
September 5, 2025